🧬 Making 90 year-olds 40 again

Welcome, humans. This is Ambrosia Path, the free weekly newsletter that helps you stay up to date on the latest longevity news in 5 minutes 🤝

Longevity Headlines

• Dr. Michael Roizen believes there is an 80% probability of aging interventions making 90-year-olds 40 again within the next decade 👵

• Curcumin may have anti-aging properties 🌶

• Longevity investment hit $3.01bn in 2023 according to Longevity.technology’s latest report 💰

• Open-source AI longevity assistant, Sequel, launched. Check it out here 🤖

• Cannabis smoking is associated with greater epigenetic age but its impact is less than cigarette smoking 🚭

• L-Nutra launched a new protein shake targeting both strength and longevity 🥤

• ‘We’re at the beginning of the second longevity revolution’ - Andrew Scott, author of The Longevity Imperative ✊

• A new hypothesis suggests dinosaurs shaped the aging rate of present-day mammals including humans 🦖

• Tally Health announced the launch of their sleep and pro-longevity supplement, Restore 💊

• NeuroSense raised $4.5m and partnered with Lonza to identify biomarkers for neurodegeneration 🧑🏻‍🔬

• A new gene therapy reverses atherosclerosis in mice 🩸

• SENS “damage-repair” longevity therapeutics can prevent and reverse Parkinson’s 🧠

• A new paper Three-Dimensional Bioprinting reviewed the latest technology for 3D printing replacement tissues and organs 🖨️

• Why exercise intensity matters for life expectancy and longevity 🏋🏻‍♂️

• Founders Forum and Longevity.Technology announced the launch of their Founders Longevity Forum event 📅

• Injecting mitochondria alleviates Parkinson’s in mice 🦠

• Mitochondrial H2O2 release does not directly cause damage to chromosomal DNA 🧬

• Your dog will have an anti-aging drug before you do 🐶

That’s it for longevity news today folks! Have a fantastic day!

Hot Tip: If this email landed in your promotions folder, move it to primary to make sure you see the next edition!

Disclaimer: This information does not constitute health and/or financial advice or a recommendation and should not be considered as such